Kidney Research and Clinical Practice10.23876/j.krcp.21.0372021403344-354Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agentsMin Hee Hong,,
International Journal of Antimicrobial Agents10.1016/s0924-8579(97)00366-x199783215-216Netilmicin serum levels in 138 cancer patients. Do they predict nephrotoxicity or therapeutic failure?V. Kcmery, J. Halko, K. Kralovicova, S. Grausova, K. Stopkova, J. Netriova,
Cancer Management and Research10.2147/cmar.s350242014225Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancerFelicity May
Infectious Agents and Cancer10.1186/1750-9378-5-s1-a4920105S1KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi's sarcomaLucas E Cavallin, Qi Ma, Pascal Goldschmidt-Clermont, Enrique A Mesri,,
Cancer Treatment Reviews10.1016/j.ctrv.2017.09.002201760120-129Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory diseaseAlessandro Broccoli, Lisa Argnani, Pier Luigi Zinzani,
Cancer Treatment Reviews10.1016/j.ctrv.2017.10.00720176161-69Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory diseaseLisa Argnani, Alessandro Broccoli, Pier Luigi Zinzani,
Drugs & Aging10.1007/s40266-018-0519-5201835293-115Pharmacotherapeutic Management of Breast Cancer in Elderly Patients: The Promise of Novel AgentsCatherine Terret, Chiara Russo,,
Discovery and Development of Anti-Breast Cancer Agents from Natural Products10.1016/b978-0-12-821277-6.00008-82021197-229Phytoestrogens as Novel Therapeutic Molecules Against Breast CancerSayanta Dutta, Sushweta Mahalanobish, Parames C. Sil,
Investigational New Drugs10.1007/s10637-016-0322-22016343364-370Effect of regulation reform on clinical trials for registering novel therapeutic agents in Taiwan: a chronological analysisI-Chen Sun, Horng-Shing Shy, Tzu-Ya Liao,,
Journal of Experimental Pharmacology10.2147/jep.s7804201121Novel compounds in the treatment of lung cancer: current and developing therapeutic agentsRudi Bao, Chan